Now showing items 1-1 of 1

    • Recombinant Human Erythropoietin in Anaemic Patients with End-Stage Renal Disease 

      Mahmoud H. Milad, Almahdi Wardami Alamen, Mutwakil G. Ahmed Fathi D. J. Bukhari (Sebha University, 2009)
      The effect of erythropoietin (EPO) on the anaemia of end-stage renal disease was investigated in 76 transfusion-dependent haemodialysis patients. EPO was administered intravenously in a dose of 50/kg, 3 times a week for ...